25-hydroxycholesterol has been researched along with Carcinoma, Hepatocellular in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 12 (57.14) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chisaki, I; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M | 1 |
| Redman, CM; Xia, H | 1 |
| Etherton, TD; Kris-Etherton, PM; Yin, D; Yu-Poth, S; Zhao, G | 1 |
| Leggiadro, C; Pezacki, JP; Rouleau, Y; Sagan, SM; Schultz, PG; Su, AI; Supekova, L | 1 |
| Hess, M; Ito, H; Schonfeld, G; Srivastava, N; Srivastava, RA | 1 |
| Conrad, DG; Jiang, G; McKenzie, TL; Shechter, I | 1 |
| Cooper, AD; Craig, WY; Everson, GT; Taniguchi, T | 1 |
| Chen, J; Cooper, AD; Taniguchi, T | 1 |
| Stephan, ZF; Yurachek, EC | 1 |
| Clark, RW; Gordon, DA; Parker, RA; Pearce, BC; Wright, JJ | 1 |
| Pinkerton, FD; Schroepfer, GJ; Spilman, CH; Via, DP | 1 |
| Bentzen, C; Berkhout, TA; Jackson, B; Niesor, E; Patel, DD; Simon, HM; Suckling, KE | 1 |
| Mugita, N; Nozawa, F; Ogawa, M; Yokoyama, S | 1 |
| Muneyuki, S; Nozawa, F; Ogawa, M; Tanaka, S; Yokoyama, S | 1 |
| Brown, MS; DeBose-Boyd, RA; Goldstein, JL; Ou, J | 1 |
| Bertrand, P; Brahimi, F; Galteau, MM; Siest, G; Starck, M | 1 |
| Dashti, N | 1 |
| Ramharack, R; Tam, SP | 1 |
| Hidaka, Y; Horie, M; Hotta, H; Iwasawa, Y; Kamei, T; Nagata, Y | 1 |
| Knight, BL; Soutar, AK; Wade, DP | 1 |
| Cimis, GM; Molowa, DT | 1 |
21 other study(ies) available for 25-hydroxycholesterol and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Immunoenzyme Techniques; Liver; Liver Neoplasms; Liver X Receptors; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Orphan Nuclear Receptors; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sulfonamides; Transfection | 2009 |
Oxysterols suppress constitutive fibrinogen expression.
Topics: Acute-Phase Reaction; alpha 1-Antitrypsin; Animals; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cholesterol; DNA-Binding Proteins; Feedback, Physiological; Fibrinogen; Gene Expression Regulation; Hepatocytes; Humans; Hydroxycholesterols; Interleukin-6; Liver Neoplasms; Liver Neoplasms, Experimental; Liver X Receptors; Orphan Nuclear Receptors; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Sulfonamides; Transcription Factors; Transfection; Tumor Cells, Cultured | 2003 |
Conjugated linoleic acid upregulates LDL receptor gene expression in HepG2 cells.
Topics: Blotting, Western; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Culture Media, Serum-Free; DNA-Binding Proteins; Fatty Acids; Gene Expression Regulation; Humans; Hydroxycholesterols; Linoleic Acids, Conjugated; Liver Neoplasms; Receptors, LDL; RNA, Messenger; Sterol O-Acyltransferase; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Tumor Cells, Cultured | 2004 |
The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication.
Topics: Anticholesteremic Agents; beta-Cyclodextrins; Carcinoma, Hepatocellular; Cells, Cultured; Cellular Structures; Cholesterol; Genome, Viral; Hepacivirus; Host-Parasite Interactions; Humans; Hydroxycholesterols; Lipid Metabolism; Lipids; Replicon; RNA, Viral; Virus Replication | 2006 |
Regulation of low density lipoprotein receptor gene expression in HepG2 and Caco2 cells by palmitate, oleate, and 25-hydroxycholesterol.
Topics: Blood; Caco-2 Cells; Carcinoma, Hepatocellular; Gene Expression Regulation; Humans; Hydroxycholesterols; Intestinal Mucosa; Liver; Liver Neoplasms; Oleic Acid; Oleic Acids; Palmitic Acid; Palmitic Acids; Receptors, LDL; Serum Albumin, Bovine; Tumor Cells, Cultured | 1995 |
Transcriptional regulation by lovastatin and 25-hydroxycholesterol in HepG2 cells and molecular cloning and expression of the cDNA for the human hepatic squalene synthase.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carcinoma, Hepatocellular; Cell Division; Cloning, Molecular; DNA, Neoplasm; Farnesyl-Diphosphate Farnesyltransferase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Kinetics; Liver; Liver Neoplasms; Lovastatin; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Rats; RNA; RNA, Messenger; Sequence Homology, Amino Acid; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Characteristics and regulation of bile salt synthesis and secretion by human hepatoma HepG2 cells.
Topics: Bile Acids and Salts; Biological Transport; Blotting, Northern; Carcinoma, Hepatocellular; Chenodeoxycholic Acid; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Liver Neoplasms; Microsomes, Liver; Progesterone; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Regulation of cholesterol 7 alpha-hydroxylase gene expression in Hep-G2 cells. Effect of serum, bile salts, and coordinate and noncoordinate regulation with other sterol-responsive genes.
Topics: Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line; Cholesterol 7-alpha-Hydroxylase; Culture Media; Culture Media, Serum-Free; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Kinetics; Lipoproteins; Lipoproteins, VLDL; Liver Neoplasms; Receptors, LDL; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1994 |
Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL.
Topics: Binding, Competitive; Carbocyanines; Carcinoma, Hepatocellular; Fluorescent Dyes; Humans; Hydroxycholesterols; Iodine Radioisotopes; Lipoproteins, LDL; Liver Neoplasms; Lovastatin; Receptors, LDL; Tumor Cells, Cultured | 1993 |
Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Topics: Acetates; Acetic Acid; Androstenes; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Chickens; CHO Cells; Cholesterol; Chromans; Cricetinae; Gene Expression Regulation, Enzymologic; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Ketoconazole; Kinetics; Liver Neoplasms; Liver Neoplasms, Experimental; Lovastatin; Mevalonic Acid; Rats; RNA Processing, Post-Transcriptional; RNA, Messenger; Suppression, Genetic; Tritium; Tumor Cells, Cultured; Vitamin E | 1993 |
Differing effects of three oxysterols on low density lipoprotein metabolism in HepG2 cells.
Topics: Carcinoma, Hepatocellular; Cholestenones; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipoproteins, LDL; Liver Neoplasms; Molecular Structure; Tumor Cells, Cultured | 1993 |
The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Topics: Acetates; Anticholesteremic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Diphosphonates; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Kinetics; Lanosterol; Lipoproteins, LDL; Liver Neoplasms; Lovastatin; Receptors, LDL; RNA, Messenger; Transcription, Genetic; Tritium; Tumor Cells, Cultured | 1996 |
Suppression of rat liver tumorigenesis by 25-hydroxycholesterol and all-trans retinoic acid: differentiation therapy for hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Transplantation; Diagnosis, Differential; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms, Experimental; Male; Rats; Tretinoin; Tumor Cells, Cultured | 1999 |
Anti-tumor effects of 25-hydroxycholesterol and low-dose recombinant tumor necrosis factor-alpha on rat liver tumorigenesis: modulated differentiation therapy for hepatocellular carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Hydroxycholesterols; Liver Neoplasms; Male; Neoplasm Transplantation; Rats; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands.
Topics: Animals; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cholesterol; DNA-Binding Proteins; Gene Expression; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ligands; Liver X Receptors; Lovastatin; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Transcription Factors; Tumor Cells, Cultured | 2001 |
Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2.
Topics: Adenylyl Cyclases; Albumins; Apolipoproteins E; Astrocytes; Astrocytoma; Carcinoma, Hepatocellular; Cell Division; Cholesterol; Chromatography, High Pressure Liquid; Colforsin; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxycholesterols; Immunoblotting; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Kinetics; Liver Neoplasms; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |
The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
Topics: Apolipoprotein A-I; Apolipoproteins B; Blotting, Northern; Carcinoma, Hepatocellular; Cholesterol; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Gene Expression; Humans; Hydroxycholesterols; Lipoproteins, LDL; Liver Neoplasms; Precipitin Tests; RNA, Messenger; Tumor Cells, Cultured | 1992 |
The effect of 25-hydroxycholesterol on the regulation of apolipoprotein E mRNA levels and secretion in the human hepatoma HepG2.
Topics: Apolipoproteins E; Carcinoma, Hepatocellular; Centrifugation; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Kinetics; Lipoproteins; Liver Neoplasms; RNA, Messenger; Sterol O-Acyltransferase; Tumor Cells, Cultured | 1992 |
Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
Topics: Acetates; Anticholesteremic Agents; Benzylamines; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Cycloheximide; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipoproteins, LDL; Liver Neoplasms; Lovastatin; Mevalonic Acid; Nucleic Acid Hybridization; Oxygenases; RNA, Neoplasm; Simvastatin; Squalene Monooxygenase; Thiophenes | 1991 |
Regulation of low-density-lipoprotein-receptor mRNA by insulin in human hepatoma Hep G2 cells.
Topics: Autoradiography; Carcinoma, Hepatocellular; Cell Line; Densitometry; DNA; Humans; Hydroxycholesterols; Insulin; Lipoproteins, LDL; Liver Neoplasms; Nucleic Acid Hybridization; Poly A; Receptors, LDL; RNA; RNA, Messenger; Tumor Cells, Cultured | 1989 |
Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells.
Topics: Carcinoma, Hepatocellular; DNA, Neoplasm; Gene Expression Regulation; Humans; Hydroxycholesterols; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Synthase; Liver Neoplasms; Lovastatin; Mevalonic Acid; Oxo-Acid-Lyases; Receptors, LDL; RNA, Messenger; Tumor Cells, Cultured | 1989 |